# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-Reuters
Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The comp...
- 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respe...